Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

Similar articles for PubMed (Select 21480671)

1.

Synthesis and evaluation of a bimodal CXCR4 antagonistic peptide.

Kuil J, Buckle T, Yuan H, van den Berg NS, Oishi S, Fujii N, Josephson L, van Leeuwen FW.

Bioconjug Chem. 2011 May 18;22(5):859-64. doi: 10.1021/bc2000947. Epub 2011 Apr 19.

2.

Synthesis and application of fluorescein- and biotin-labeled molecular probes for the chemokine receptor CXCR4.

Oishi S, Masuda R, Evans B, Ueda S, Goto Y, Ohno H, Hirasawa A, Tsujimoto G, Wang Z, Peiper SC, Naito T, Kodama E, Matsuoka M, Fujii N.

Chembiochem. 2008 May 5;9(7):1154-8. doi: 10.1002/cbic.200700761.

PMID:
18412193
3.

Hybrid peptide dendrimers for imaging of chemokine receptor 4 (CXCR4) expression.

Kuil J, Buckle T, Oldenburg J, Yuan H, Borowsky AD, Josephson L, van Leeuwen FW.

Mol Pharm. 2011 Dec 5;8(6):2444-53. doi: 10.1021/mp200401p. Epub 2011 Nov 15.

4.

Concise site-specific synthesis of DTPA-peptide conjugates: application to imaging probes for the chemokine receptor CXCR4.

Masuda R, Oishi S, Ohno H, Kimura H, Saji H, Fujii N.

Bioorg Med Chem. 2011 May 15;19(10):3216-20. doi: 10.1016/j.bmc.2011.03.059. Epub 2011 Apr 2.

PMID:
21524584
5.

111In-Labeled Ac-TZ14011 peptide (a chemokine receptor 4 antagonist) conjugated to CyAL5.5 (a fluorescent dye) through a multifunctional single-attachment point (MSAP) reagent.

Chopra A.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2012 Nov 29 [updated 2012 Dec 27].

6.

Development of a 111In-labeled peptide derivative targeting a chemokine receptor, CXCR4, for imaging tumors.

Hanaoka H, Mukai T, Tamamura H, Mori T, Ishino S, Ogawa K, Iida Y, Doi R, Fujii N, Saji H.

Nucl Med Biol. 2006 May;33(4):489-94. Epub 2006 May 2.

PMID:
16720240
7.

Peptide-functionalized luminescent iridium complexes for lifetime imaging of CXCR4 expression.

Kuil J, Steunenberg P, Chin PT, Oldenburg J, Jalink K, Velders AH, van Leeuwen FW.

Chembiochem. 2011 Aug 16;12(12):1897-903. doi: 10.1002/cbic.201100271. Epub 2011 Jul 7.

PMID:
21739561
8.

Use of a single hybrid imaging agent for integration of target validation with in vivo and ex vivo imaging of mouse tumor lesions resembling human DCIS.

Buckle T, Kuil J, van den Berg NS, Bunschoten A, Lamb HJ, Yuan H, Josephson L, Jonkers J, Borowsky AD, van Leeuwen FW.

PLoS One. 2013;8(1):e48324. doi: 10.1371/journal.pone.0048324. Epub 2013 Jan 11.

9.

Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.

Achilefu S, Srinivasan A, Schmidt MA, Jimenez HN, Bugaj JE, Erion JL.

J Med Chem. 2003 Jul 17;46(15):3403-11.

PMID:
12852770
10.

Design, synthesis, and characterization of a dual modality positron emission tomography and fluorescence imaging agent for monoclonal antibody tumor-targeted imaging.

Xu H, Baidoo K, Gunn AJ, Boswell CA, Milenic DE, Choyke PL, Brechbiel MW.

J Med Chem. 2007 Sep 20;50(19):4759-65. Epub 2007 Aug 29.

11.

Development and application of fluorescent SDF-1 derivatives.

Masuda R, Oishi S, Tanahara N, Ohno H, Hirasawa A, Tsujimoto G, Kodama E, Matsuoka M, Fujii N.

Future Med Chem. 2012 May;4(7):837-44. doi: 10.4155/fmc.12.31.

PMID:
22571609
12.

Site-specific conjugation of a lanthanide chelator and its effects on the chemical synthesis and receptor binding affinity of human relaxin-2 hormone.

Shabanpoor F, Bathgate RA, Belgi A, Chan LJ, Nair VB, Wade JD, Hossain MA.

Biochem Biophys Res Commun. 2012 Apr 6;420(2):253-6. doi: 10.1016/j.bbrc.2012.02.141. Epub 2012 Mar 7.

PMID:
22425984
13.

Synthesis and biological studies of nociceptin derivatives containing the DTPA chelating group for further labeling with therapeutic radionuclides.

Ligeti M, Gündüz O, Magyar A, Kató E, Rónai AZ, Vita C, Varga I, Hudecz F, Tóth G, Borsodi A, Benyhe S.

Peptides. 2005 Jul;26(7):1159-66. Epub 2005 Mar 2.

PMID:
15949634
14.

Fluorescent and lanthanide labeling for ligand screens, assays, and imaging.

Josan JS, De Silva CR, Yoo B, Lynch RM, Pagel MD, Vagner J, Hruby VJ.

Methods Mol Biol. 2011;716:89-126. doi: 10.1007/978-1-61779-012-6_6.

16.

Immunohistochemical detection of the CXCR4 expression in tumor tissue using the fluorescent peptide antagonist Ac-TZ14011-FITC.

van den Berg NS, Buckle T, Kuil J, Wesseling J, van Leeuwen FW.

Transl Oncol. 2011 Aug;4(4):234-40. Epub 2011 Aug 1.

17.

Impact of bifunctional chelators on biological properties of 111In-labeled cyclic peptide RGD dimers.

Shi J, Kim YS, Chakraborty S, Zhou Y, Wang F, Liu S.

Amino Acids. 2011 Nov;41(5):1059-70. doi: 10.1007/s00726-009-0439-0. Epub 2010 Jan 6.

PMID:
20052508
19.

Near-infrared-labeled peptide multimer functions as phage mimic for high affinity, specific targeting of colonic adenomas in vivo (with videos).

Joshi BP, Liu Z, Elahi SF, Appelman HD, Wang TD.

Gastrointest Endosc. 2012 Dec;76(6):1197-206.e1-5. doi: 10.1016/j.gie.2012.07.017. Epub 2012 Sep 27.

20.

In vivo imaging of mesenchymal-epithelial transition factor (c-Met) expression using an optical imaging system.

Kim EM, Park EH, Cheong SJ, Lee CM, Jeong HJ, Kim DW, Lim ST, Sohn MH.

Bioconjug Chem. 2009 Jul;20(7):1299-306. doi: 10.1021/bc8005539.

PMID:
19534520
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk